Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: HoLEP Vs BPEP for Large Prostatic Adenoma [Phase 3]
Phase 3 trial comparing HoLEP and BPEP for large prostatic adenoma has completed.
-
FDA approval · 2020-05-22FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for UROXATRAL (alfuzosin HCl) submitted by Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Urodynamic Feasibility Study Utilizing the UroLift® System [NA]
Clinical trial update reporting a feasibility study using the UroLift system for benign prostatic hyperplasia has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-04-17Clinical Trial Update: Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. [Phase 1]
A Phase 1 trial assessing the bioequivalence of two formulations of tamsulosin hydrochloride capsules in fed male participants with prostati…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the effects of Traditional Chinese Medicine on benign prostatic hyperplasia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) [NA]
Clinical trial update for Waterjet Ablation Therapy (WATER) evaluating endoscopic resection of prostate tissue in Benign Prostatic Hyperplas…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia [NA]
Completed clinical trial evaluating prostate artery embolization for symptomatic benign prostatic hyperplasia with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Real World Data on Management of Male LUTS
Real-world data study on management of male lower urinary tract symptoms (Benign Prostatic Hyperplasia) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. [Phase 1]
Phase 1 trial evaluating bioequivalence of two tamsulosin HCl capsule formulations in fasted male subjects completed with posted results.
-
FDA approval · 2020-02-21FDA Approved: TADALAFIL — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for tadalafil submitted by Dr.Reddys Laboratories Inc.
-
FDA approval · 2020-02-14FDA Approved: SILODOSIN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for generic silodosin for the treatment of signs and symptoms of benign prostatic …
-
FDA label_change · 2020-01-30FDA Approved: AVODART — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for AVODART (dutasteride) filed by Waylis Therapeutics LLC, resulting in changes to the product labe…
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH) [Phase 4]
Phase 4 trial comparing alpha blocker monotherapy versus 5ARI monotherapy after combination therapy in benign prostatic hyperplasia has been…
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH [Phase 2]
Phase 2 efficacy study comparing HoLEP and TURP for lower urinary tract symptoms due to benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH) [Phase 4]
A Phase 4 trial comparing doxazosin plus tolterodine SR 2 mg vs 4 mg in men with overactive bladder and benign prostatic hyperplasia to asse…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Prostate Embolization for Benign Prostatic Hyperplasia [Phase 1, Phase 2]
Clinical trial update for prostate embolization in benign prostatic hyperplasia reported completed phases 1 and 2 with results posted.
-
FDA approval · 2019-11-22FDA Approved: SILODOSIN — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original ANDA for silodosin submitted by Alembic Pharmaceuticals Limited, establishing a generic version of silodosin for t…
-
FDA approval · 2019-10-16FDA Approved: TADALAFIL — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original ANDA for tadalafil, enabling a generic version of the medication.
-
FDA approval · 2019-10-07FDA Approved: TADALAFIL — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Macleods Pharmaceuticals Limited's original application for tadalafil (TADALAFIL) as a generic product.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) [Phase 4]
Phase 4 trial evaluating mirabegron for overactive bladder symptoms in men taking tamsulosin for lower urinary tract symptoms due to benign …
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Optimizing Pain Control in Transurethral Resection of the Prostate [Phase 4]
Phase 4 clinical trial updating pain control strategies for patients with benign prostatic hyperplasia and urinary obstruction.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) [Phase 4]
Phase 4 clinical trial update evaluating the efficacy of silodosin for symptomatic benign prostatic hyperplasia has been completed.
-
FDA approval · 2019-09-23FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for tamsulosin hydrochloride submitted by Ascend Laboratories, LLC.
-
FDA approval · 2019-09-23FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for tamsulosin hydrochloride submitted by Macleods Pharmaceuticals Limited. The approval relates…
-
FDA approval · 2019-09-09FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for tamsulosin hydrochloride submitted by Sun Pharmaceutical Industries, Inc.